| Year |
Citation |
Score |
| 2020 |
Kohli M, Tan W, Zheng T, Wang A, Huo Y, Montesinos C, Wong C, Du P, Jia S, Yu J. Plasma circulating tumor DNA (ctDNA) based clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 38: 160-160. DOI: 10.1200/Jco.2020.38.6_Suppl.160 |
0.31 |
|
| 2019 |
Kohli M, Yadav S, Tan W, Riaz IB, Zheng T, Wang A, Montesinos C, Wong C, Du P, Jia S, Yu J. Plasma cell-free DNA-based prognosis in metastatic hormone sensitive prostate cancer. Journal of Clinical Oncology. 37: 242-242. DOI: 10.1200/Jco.2019.37.7_Suppl.242 |
0.304 |
|
| 2019 |
Kohli M, Tan W, Zheng T, Wang A, Wong C, Tan M, Jia S, Yu J. Plasma cell free DNA (cfDNA) based somatic aberrations detected in treatment naïve metastatic hormone sensitive prostate cancer (mHSPC), hormonally ablated mHSPC and metastatic castration resistant prostate cancer (mCRPC) states and their impact on survival. Journal of Clinical Oncology. 37: 5047-5047. DOI: 10.1200/Jco.2019.37.15_Suppl.5047 |
0.3 |
|
| 2018 |
Wang A, Zhao Z, Xie C, Cheung T, Montesinos C, Zhang P, Du P, Yu J, Jia S. Abstract 3670: Urine- and blood-based DNA+RNA liquid biopsy tests in prostate, bladder and kidney cancers Cancer Research. 78: 3670-3670. DOI: 10.1158/1538-7445.Am2018-3670 |
0.314 |
|
| 2002 |
Wang A, Kurdistani SK, Grunstein M. Requirement of Hos2 histone deacetylase for gene activity in yeast. Science (New York, N.Y.). 298: 1412-4. PMID 12434058 DOI: 10.1126/Science.1077790 |
0.474 |
|
| 2002 |
Robyr D, Suka Y, Xenarios I, Kurdistani SK, Wang A, Suka N, Grunstein M. Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases. Cell. 109: 437-46. PMID 12086601 DOI: 10.1016/S0092-8674(02)00746-8 |
0.48 |
|
| Show low-probability matches. |